ArticleFrontiers in oncology2023

BAT6026, a novel anti-OX40 antibody with enhanced antibody dependent cellular cytotoxicity effect for cancer immunotherapy.

Shizhong Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.